CVM : Summary for Cel-Sci Corporation ($0.001 Pa - Yahoo Finance

U.S. Markets close in 6 hrs 6 mins

CEL-SCI Corporation (CVM)


NYSE MKT - NYSE MKT Real Time Price. Currency in USD
Add to watchlist
0.09-0.01 (-6.28%)
As of 9:54AM EST. Market open.
People also watch
HEBCTICCYTRGNBTAGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.10
Open0.09
Bid0.00 x
Ask0.00 x
Day's Range0.09 - 0.10
52 Week Range0.06 - 0.66
Volume347,625
Avg. Volume3,234,647
Market Cap17.66M
Beta-0.31
PE Ratio (TTM)-1.08
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire3 days ago

    CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference

    CEL-SCI Corporation today announced that Dr. Daniel Zimmerman, its Senior V.P of Research, Cellular Immunology, presented data with a LEAPS Rheumatoid Arthritis therapeutic vaccine at Madridge‘s International Conference on Vaccines held in Baltimore, MD on February 20-22, 2017.

  • Business Wire7 days ago

    CEL-SCI Announces $1.0 Million Registered Direct Offering

    CEL-SCI Corporation today announced it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $1.0 million in a registered direct offering.

  • Associated Press15 days ago

    Cel-Sci posts 1Q profit

    On a per-share basis, the Vienna, Virginia-based company said it had net income of 1 cent. The cancer immunotherapy company posted revenue of $7,300 in the period. Its adjusted revenue was $7,000. In the ...